Comerica Bank’s Beam Therapeutics BEAM Stock Holding History

Comerica Bank’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$14.7K	Buy	530 +59	+13%	+$1.5K	﹤0.01%	3163
2025 Q3	$11.4K	Sell	471 -105	-18%	-$2.09K	﹤0.01%	3219
2025 Q2	$9.8K	Sell	576 -245	-30%	-$4.27K	﹤0.01%	3215
2025 Q1	$16K	Sell	821 -52	-6%	-$1.36K	﹤0.01%	3067
2024 Q4	$21.6K	Buy	873 +125	+17%	+$3.19K	﹤0.01%	3008
2024 Q3	$18.3K	Buy	748 +17	+2%	+$439	﹤0.01%	3054
2024 Q2	$17.1K	Sell	731 -134	-15%	-$3.29K	﹤0.01%	3034
2024 Q1	$28.6K	Sell	865 -108	-11%	-$3.37K	﹤0.01%	2930
2023 Q4	$26.5K	Buy	973 +435	+81%	+$10.8K	﹤0.01%	2900
2023 Q3	$12.9K	Buy	+538	New	+$14.4K	﹤0.01%	3141

Other funds holding BEAM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Comerica Bank's BEAM Position: Q4 2025 in Review

Comerica Bank increased its Beam Therapeutics (BEAM) stake by 13% in Q4 2025, buying an estimated $1.5K and bringing the position to 530 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3163.

Comerica Bank first reported a position in BEAM in Q3 2023 and has held it in 10 quarters since. The position peaked at $28.6K in Q1 2024. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

Comerica Bank held 530 shares of Beam Therapeutics worth $14.7K as of Q4 2025.
Comerica Bank bought 59 Beam Therapeutics shares in Q4 2025, an estimated $1.5K.
Beam Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3163 holding.
Comerica Bank first reported a position in Beam Therapeutics in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Beam Therapeutics position peaked at $28.6K in Q1 2024.
246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.